Brief: Talis Biomedical Granted FDA Emergency Use Authorization (Eua) For Covid-19 Molecular Point-Of-Care Test To Detect Sars-Cov-2

Talis Biomedical

08/11/2021 14:02

Nov 8 (Reuters) - Talis Biomedical Corp  TLIS.O :
    * TALIS BIOMEDICAL GRANTED FDA EMERGENCY USE AUTHORIZATION
(EUA)
FOR COVID-19 MOLECULAR POINT-OF-CARE TEST TO DETECT SARS-COV-2

Source text for Eikon:  ID:nGNX55LB6c 
Further company coverage:  TLIS.O 

 ((Reuters.Briefs@thomsonreuters.com;))